News & Updates
Filter by Specialty:

Renal denervation bounces back in 3-year follow-up study
Following negative primary results, the final follow-up of the SYMPLICITY HTN-3 trial takes a turn for the better, demonstrating significant blood pressure (BP) reductions with renal denervation (RDN) in patients with uncontrolled hypertension (HTN).
Renal denervation bounces back in 3-year follow-up study
29 Sep 2022
Molnupiravir and nirmatrelvir/ritonavir show favourable hepatic safety in COVID-19 patients in HK
A territory-wide cohort study in Hong Kong shows favourable hepatic safety profile with the oral antivirals, molnupiravir and nirmatrelvir/ritonavir, in COVID-19 patients, including those at risk of drug-induced liver injury (DILI).
Molnupiravir and nirmatrelvir/ritonavir show favourable hepatic safety in COVID-19 patients in HK
29 Sep 2022
New ROTA imaging technique improves early diagnosis of glaucoma
Researchers from the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have jointly developed an advanced imaging technique for retinal nerve fibre layer optical texture analysis (ROTA) that can improve the detection of early optic nerve damage in glaucoma.
New ROTA imaging technique improves early diagnosis of glaucoma
29 Sep 2022
Telepsychiatry as reliable as face-to-face interviews for symptom assessment
Assessments of depressive, anxiety and psychotic symptoms and suicidal risk by telepsychiatry have good reliability in general when compared with face-to-face interviews, according to researchers from the Queen Mary Hospital (QMH).
Telepsychiatry as reliable as face-to-face interviews for symptom assessment
29 Sep 2022
Adjuvant pembrolizumab continues to improve DFS in clear cell RCC
In patients with clear cell renal cell carcinoma (RCC), adjuvant pembrolizumab continues to improve disease-free survival (DFS) over placebo, according to extended follow-up of the phase III KEYNOTE-564 trial.